Notification of Preliminary Results
2nd February 2006
Intercytex Group plc (LSE: ICX), a UK-based emerging healthcare
company developing cell therapy products for the woundcare and
aesthetic medicine markets, today announces that it will report its
preliminary results for the year ending 31 December 2005 on
Wednesday 8 March 2006.
Enquiries:
Intercytex Group plc
Richard Moulson, Chief Financial Officer
Tel: 0161 904 4523
Financial Dynamics
Claire Rowell
Tel: 020 7831 3113
|
Contact Us
